A research instrument produces a number. But how do we know it represents what the instrument claims to measure? As skin research becomes increasingly data-driven, this question deserves as much attention as the results themselves.
Validation is not a single milestone
It is tempting to think of validation as a box that can be checked once a study is published. In practice, scientific confidence develops through different forms of evidence. One study may compare a measurement with a reference method; another may test whether it responds to a known biological change; others may assess performance across populations and settings. Together, they form a more informative picture than any one result. These complementary forms of evidence are illustrated in the SIAscopy™ literature (Moncrieff et al., 2002; Matts et al., 2007; Ud-Din et al., 2015).
What evidence matters?
Biological relevance, agreement with independent methods, consistency, and suitability for the intended application each answer different questions. An instrument can be consistent without necessarily measuring the intended biological property. And a result shown in one setting may not establish performance in another. For example, tissue comparisons and biological corroboration answer different questions (Matts et al., 2007; Ud-Din et al., 2015).
Why CROs should care
Endpoint choice affects protocol design, interpretation, and the conclusions a sponsor can responsibly draw. Understanding the evidence behind a measurement helps teams distinguish biological change from measurement variation and avoid claims that exceed the data. See the endpoint-specific evidence discussed by Matts et al. (2007) and Ud-Din et al. (2015).
Two decades of scientific evidence
SIAscopy™ is supported by more than two decades of published scientific research. Eumelanin measurement has been validated against histology and tissue assay across Fitzpatrick skin types I–VI (Matts et al., 2007), while independent immunohistochemical findings have corroborated the biological interpretation of haemoglobin and collagen measurements (Ud-Din et al., 2015).
The scientific foundations of SIAscopy™ trace back to the work of Cotton and Claridge (1996), followed by its description in peer-reviewed literature by Moncrieff and colleagues (2002). Subsequent research has explored applications in pigmentation, including controlled cosmetic studies (Kimball et al., 2010), photodamaged skin (Stimpfle et al., 2015), and wound healing (Ud-Din et al., 2015).
Together, these studies demonstrate the breadth of the published evidence while recognizing an important scientific distinction: the nature and strength of validation differ by endpoint.
Closing
The better question is not simply “Can this technology produce quantitative data?” It is “What evidence allows us to trust what the data mean?” For research teams, that question is a foundation for better study design. For published examples, see Moncrieff et al. (2002), Matts et al. (2007), and Ud-Din et al. (2015).
Learn more about SkinSecure™ and the evidence behind the SIAscopy method at medxhealth.com/skinsecure and stay tuned for more on this topic in December.

